Fingerprint
Dive into the research topics of 'A phase I study of abiraterone acetate combined with BEZ235, a dual PI3K/mTOR inhibitor, in metastatic castration resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically